Skip to main content

Global $16.4 Billion Infusion Pumps Markets - Trajectory & Analytics, 2012-2019 & 2020-2027 - ResearchAndMarkets.com

The "Infusion Pumps - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Infusion Pumps estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$16.4 Billion by 2027, growing at a CAGR of 4.3% over the analysis period 2020-2027.

Volumetric Infusion Pumps, one of the segments analyzed in the report, is projected to record a 4.4% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Insulin Infusion Pumps segment is readjusted to a revised 4.4% CAGR for the next 7-year period.

The U. S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 7.7% CAGR

The Infusion Pumps market in the U. S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2027 trailing a CAGR of 7.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Ambulatory Infusion Pumps Segment to Record 3.9% CAGR

In the global Ambulatory Infusion Pumps segment, USA, Canada, Japan, China and Europe will drive the 3.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$727.2 Million in the year 2020 will reach a projected size of US$920.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.4 Billion by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Infusion Pumps: An Alternate Drug Delivery Option
  • Recent Market Activity
  • Current and Future Analysis
  • Developed Economies Dominate Infusion Pumps Market
  • Asia-Pacific: The Fastest Growing Market for Infusion Pumps
  • Analysis by Product Segments
  • Infusion Errors & Technology Defenses Developed Over the Years
  • Rise in Incidence of Chronic Diseases Fuels Infusion Pumps Demand
  • The Diabetes Epidemic - Untapped Potential for Insulin Pumps
  • Global Diabetes Expenditure: Opportunity Indicator for Insulin Pumps Market
  • Cancer Pain Offers Potential Opportunities for Pain Management Pumps
  • Global Competitor Market Shares
  • Infusion Pumps Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

  • Animas Corporation (USA)
  • Baxter International Inc. (USA)
  • B. Braun Melsungen AG (Germany)
  • Becton, Dickinson and Company (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Fresenius SE & Co. KGaA (Germany)
  • Halyard Health, Inc. (USA)
  • Hospira, Inc. (USA)
  • ICU Medical, Inc. (USA)
  • Insulet Corporation (USA)
  • Medtronic, PLC (Ireland)
  • Moog, Inc. (USA)
  • Smiths Medical (USA)
  • Sooil Development Co. Ltd. (Korea)
  • Tandem Diabetes Care, Inc. (USA)
  • Teleflex Incorporated (USA)
  • Terumo Corporation (Japan)

3. MARKET TRENDS & DRIVERS

  • Infusion Errors: A Key Driving Force for Newer Technologies
  • Manufacturers Focus on Interoperability with EMR Systems
  • Security of Wireless Medical Device - A Vital Factor
  • Shift from Hospital Environments to Alternative-Sites/Home Settings Drives the market for Home Infusion Pumps
  • Product Complexity Thwarts ROI on Devices
  • Smart Pump Technology: A Major Growth Driver
  • Smart Pumps with Innovative Features
  • Improving Functionality for Enhanced Patient Compliance
  • Maintaining Smartness Quotient of Smart Infusion Pumps
  • Product Bundling: A Double Whammy Success
  • Analgesia Infusion Pumps Continue to Register Favorable Growth
  • Disposable Ambulatory Infusion Pumps Market Exhibits Notable Stride Forward
  • Enteral Feeding Pumps Market Overview
  • Replacements Offer Potential Growth Opportunities
  • Preference for Enteral Nutrition over Parenteral Nutrition Bodes Well
  • Enteral Nutrition Therapy in Treating Adult Malnutrition Offers Growth Opportunities
  • Home Enteral Therapy to Boost Demand for Enteral Feeding Devices
  • Insulin Pumps - Designed for Optimum Disease Management
  • The Rise of Smart Pumps
  • Manufacturers Eye Type II Diabetes Market
  • Implantable Insulin Pumps - The Next Generation of Insulin Pumps
  • Patch Pumps Gain Manufacturer Attention
  • Insulin Pump Training - An Important Driver
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
  • Competition from Other Insulin Delivery Technologies Continues
  • Maturity Hits Volumetric Infusion Pumps Market
  • Equipment Recalls Thwarts Growth Prospects
  • Stringent Safety Regulations Impede Time-to-Market
  • Look into Select Technology Advancements
  • Innovfusion Develops Advanced Infusion Pumps to Provide Relief from Labor Pain
  • Summit Medical's Low-Cost Portable Infusion Pumps Improve Patient Care
  • Product Malfunctioning Erodes Penetration of Implantable Infusion Pumps

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

AFRICA

IV. COMPETITION

  • Total Companies Profiled: 52

For more information about this report visit https://www.researchandmarkets.com/r/qd20y2

Contacts:

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.